Novel Treatment for Pancreatic Cancer Discovered
Researchers from the University of Pennsylvania have reported of developing a new approach to kill the tumor in the pancreas. The technique is termed as novel by the experts. The details of the research study are published in the March 25th 2011 issue of the journal Science.
Prior to this research the experts believed that a cancer drug must attack the chunk of malignant cells to treat the disease. The present study presented them a new approach where the tissues surrounding the tumor were targeted. It led to the shrinking of the tumor as well.
The feat was achieved by the experts by binding an experimental antibody CD40 with the standard chemotherapy drug gemcitabine.
43,140 new cases of pancreatic cancer were reported in the United States last year. 36,800 people died owing to this cancer. These are the statistics provided by the National Cancer Institute.
Though surgery, radiation therapy and chemotherapy are the standard treatments to address this cancer, they are partially effective and have severe risk factors.